Next Financial Group’s Aldeyra Therapeutics ALDX Stock Holding History

Next Financial Group’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Hold	340	–	–	﹤0.01%	2688
2021 Q3	$3K	Hold	340	–	–	﹤0.01%	2352
2021 Q2	$4K	Hold	340	–	–	﹤0.01%	2231
2021 Q1	$4K	Hold	340	–	–	﹤0.01%	2139
2020 Q4	$2K	Hold	340	–	–	﹤0.01%	2161
2020 Q3	$3K	Buy	+340	New	+$2.2K	﹤0.01%	1947
2017 Q3	–	Sell	-2,000	Closed	-$9K	–	1741
2017 Q2	$9K	Buy	+2,000	New	+$9.2K	﹤0.01%	1335

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Next Financial Group's ALDX Position: Q4 2021 in Review

Next Financial Group held its Aldeyra Therapeutics (ALDX) position steady in Q4 2021 at 340 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2688.

Next Financial Group first reported a position in ALDX in Q2 2017 and has held it in 7 quarters since. The position peaked at $9K in Q2 2017. 115 funds tracked by Wall St. Rank hold ALDX as of Q4 2021.

Next Financial Group held 340 shares of Aldeyra Therapeutics worth $1K as of Q4 2021.
Next Financial Group left its Aldeyra Therapeutics share count unchanged in Q4 2021.
Aldeyra Therapeutics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2688 holding.
Next Financial Group first reported a position in Aldeyra Therapeutics in Q2 2017 and has held it in 7 quarters since.
Next Financial Group's Aldeyra Therapeutics position peaked at $9K in Q2 2017.
115 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.